Edition:
United Kingdom

People: Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

7.57HKD
23 Apr 2019
Change (% chg)

HK$-0.23 (-2.95%)
Prev Close
HK$7.80
Open
HK$7.80
Day's High
HK$7.85
Day's Low
HK$7.53
Volume
59,040,348
Avg. Vol
65,089,283
52-wk High
HK$13.93
52-wk Low
HK$4.53

Wang, Minggang 

Mr. Wang Minggang serves as Vice Chairman of the Board and the General Manager of Qingdao Haier of Sino Biopharmaceutical Ltd. He is a Master degree postgraduate, a practicing doctor and a senior engineer, and is the vice president and the general manager of Qingdao CT. Mr. Wang joined the Group in September, 2008. He had worked in some large domestic and foreign pharmaceutical companies and was the general manager of Qingdao Haier Pharmaceutical Co. Ltd and the head of the biological division of the Haier Group. He has more than 30 years of management experience in pharmaceutical industry. Mr. Wang is the chairman of Qingdao Pharmaceutical Profession Association, a vice chairman of the Shandong Province Pharmaceutical Profession Association, as well as a delegate to the Committee of the 15th and 16th Chinese People’s Political Consultative Conference of Qingdao City. Mr. Wang has received various recognitions in recent years, such as Qingdao Distinguished Talent, Shandong Province Technology Advancement Second Honour Award, Qingdao Technology Advancement Third Honour Award, and Shangdong Province Invention and Entrepreneurship First Honour Award.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Y Y Tse

8,870,000

Ping Tse

36,727,000

Cheung Ling Cheng

11,116,000

Minggang Wang

--

Chun Ling Li

--

Hsin Tse

2,180,000
As Of  31 Dec 2017